๐งฌ GLP-1 vs GLP2TZ vs GLP3RT: What's the Difference?
Category: GLP Research
Reading Time: 8 minutes
Last Reviewed: August 2026
Introduction
As peptide research has expanded, several compounds have become widely studied for how they interact with the body's metabolic signaling systems. Three of the most recognized are GLP-1 receptor agonists, dual GIP/GLP-1 receptor agonists, and triple receptor agonists.
Although these compounds share similarities, they differ in the number of biological receptor systems they are designed to activate. Understanding these differences can help explain why researchers continue investigating each class separately.
This article provides an educational overview of GLP1SM (Semaglutide), GLP2TZ (Tirzepatide), and GLP3RT (Retatrutide).
Quick Comparison
Feature GLP1SM (Semaglutide) GLP2TZ (Tirzepatide) GLP3RT (Retatrutide)
Receptor Activity GLP-1 GLP-1 + GIP GLP-1 + GIP + Glucagon
Number of Receptors 1 2 3
Molecule Type Synthetic peptide Synthetic peptide Synthetic peptide
Research Focus GLP-1 signaling Dual hormone signaling Triple hormone signaling
Current Research Status Extensive Extensive Emerging
Understanding the Three Receptor Systems
GLP-1 Receptor
GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone involved in regulating glucose metabolism, digestion, and appetite signaling.
Researchers study GLP-1 receptor activation to better understand metabolic regulation and endocrine communication.
GIP Receptor
Glucose-dependent insulinotropic polypeptide (GIP) is another naturally occurring hormone involved in metabolic signaling.
Scientists continue investigating how GIP interacts with GLP-1 pathways and how the two systems work together.
Glucagon Receptor
Glucagon is a hormone involved in maintaining glucose availability and regulating energy metabolism.
Adding glucagon receptor activity introduces another area of investigation into how multiple hormonal pathways interact.
GLP1SM (Semaglutide)
GLP1SM is designed to activate only the GLP-1 receptor.
Researchers study it primarily to understand:
- GLP-1 biology
- Hormonal signaling
- Metabolic regulation
- Endocrine physiology
- Cellular communication
Because it targets a single receptor pathway, GLP1SM is often used as a reference point when comparing newer multi-receptor compounds.
GLP-1 is a hormone naturally produced by specialized cells in the small intestine after eating. It is part of the body's incretin system and plays an important role in coordinating metabolic signaling.
Researchers study GLP-1 because it is involved in:
- Blood glucose regulation
- Communication between the digestive system and pancreas
- Appetite-related signaling
- Gastric emptying
- Insulin and glucagon signaling
- Energy balance
GLP-1 receptor agonists, such as Semaglutide (GLP1SM), are designed to activate this receptor pathway
GLP2TZ (Tirzepatide)
GLP2TZ activates two receptor systems:
- GLP-1
- GIP
Scientists continue studying how activation of these two pathways may differ from compounds that target only GLP-1 receptors.
Research involving GLP2TZ focuses on understanding interactions between multiple metabolic signaling systems.
GLP-2 is a hormone naturally produced by specialized L cells in the small intestine after eating. Like GLP-1, it is derived from the proglucagon molecule and released as part of the body's response to food intake. However, GLP-2 primarily functions within the gastrointestinal system rather than metabolic regulation.
Researchers study GLP-2 because it is involved in:
- Intestinal growth and maintenance
- Nutrient absorption
- Gut barrier integrity
- Intestinal blood flow
- Gastrointestinal repair and adaptation
- Digestive system signaling
- Communication between intestinal cells and surrounding tissues
GLP-2 receptor agonists, such as Teduglutide, are designed to activate this receptor pathway and have been studied for their effects on intestinal physiology and gastrointestinal function.
GLP3RT (Retatrutide)
GLP3RT represents the newest generation of compounds currently under investigation.
Unlike earlier compounds, it interacts with three receptor systems:
- GLP-1
- GIP
- Glucagon
Researchers continue studying how simultaneous activation of these three pathways influences endocrine signaling and metabolic regulation.
Unlike GLP-1 and GLP-2, GLP-3 is not a naturally occurring hormone found in the human body. Instead, the term "GLP-3" is commonly used to describe a new generation of triple receptor agonist research compounds, such as Retatrutide (GLP3RT).
Rather than activating a single hormone pathway, triple agonists are designed to interact with three naturally occurring receptor systems:
- GLP-1 receptor
- GIP receptor
- Glucagon receptor
Researchers study triple receptor agonists because they combine multiple metabolic signaling pathways into a single molecule.
Current areas of research include:
- Multi-receptor metabolic signaling
- Endocrine communication
- Energy balance
- Glucose regulation
- Lipid metabolism
- Hormonal pathway interactions
- Whole-body metabolic physiology
Triple receptor agonists, such as Retatrutide (GLP3RT), are designed to activate all three receptor pathways simultaneously, making them an active area of metabolic and endocrine research.
Why Are Scientists Interested in Multi-Receptor Peptides?
One area of modern peptide research involves understanding whether activating multiple receptor systems produces different biological responses compared with activating a single receptor.
Current investigations explore:
- Hormonal communication
- Cellular signaling
- Endocrine regulation
- Energy metabolism
- Receptor interactions
Research in this area continues to evolve, and scientists are still learning how these signaling pathways work together.
Side-by-Side Summary
Compound Primary Scientific Interest
GLP1SM GLP-1 receptor biology
GLP2TZ Dual receptor signaling
GLP3RT Triple receptor signaling
Frequently Asked Questions
Are these the same compound?
No. Although they belong to a related class of research peptides, each compound has a different molecular structure and interacts with a different combination of biological receptors.
Why is GLP3RT called a "triple agonist"?
Because researchers study it for its interaction with three receptor systems:
- GLP-1
- GIP
- Glucagon
Does more receptors automatically mean better?
Not necessarily. The number of receptor systems involved does not determine superiority. Each compound is investigated for different scientific questions, and researchers continue evaluating how these signaling pathways function individually and together.
Why are these compounds compared so often?
Because they represent successive generations of peptide research, with each newer compound expanding the number of receptor pathways under investigation.
Key Takeaways
โ GLP1SM targets one receptor (GLP-1).
โ GLP2TZ targets two receptors (GLP-1 and GIP).
โ GLP3RT targets three receptors (GLP-1, GIP, and glucagon).
โ All three remain important areas of scientific research, but they differ in structure and receptor activity.
Continue Learning
- What Are Peptides?
- GLP1SM (Semaglutide)
- GLP2TZ (Tirzepatide)
- GLP3RT (Retatrutide)
- Understanding the Endocrine System
- What Is a Certificate of Analysis (COA)?
- Glossary of Research Terms
Educational Notice
This article is intended solely for educational and informational purposes. It summarizes scientific terminology, biological mechanisms, and areas of published research. It does not establish the safety, effectiveness, identity, purity, or approved use of any particular research material. Nothing in this article should be interpreted as medical advice, treatment guidance, dosing information, or a recommendation for human or animal use. ResearchPeps products are offered strictly for laboratory research purposes.